Team
We are pursuing molecular imaging using molecular targeted microbubble-based contrast agents and catheter-based ultrasound imaging and drug delivery. These two focus areas are funded by multi-year NIH RO1s. We are also pursuing projects in photoacoustics, ultrasound image guided radiation oncology (breast cancer applications primarily) and in the use of ultrasound for prevention of ischemia-reperfusion injury.
John A. Hossack
John A. Hossack develops ultrasound imaging approaches for cardiovascular disease, including mouse heart imaging, catheter-based imaging and drug delivery, and molecular imaging for diagnosing stroke risk. He obtained B.Eng. and Ph.D. degrees in Electrical and Electronic Engineering, University of Strathclyde and his postdoc at Stanford University.
Graduate Students
-
Yanjun Xie, MS
PhD Candidate
Research interest: Ultrasound localization microscopy; Intravascular ultrasound and therapy; Modeling of elastography.
-
Yi Huang
PhD Candidate
Research interest: Ultrasound molecular imaging for cardiovascular disease; Signal processing and deep learning methods in ultrasound imaging; Ultrasound super-resolution imaging.
Alumni
-
Sushanth Sathyanarayana, PhD
Developing novel signal processing and machine learning methods for artifact reduction and accelerated imaging in ultrasound and photoacoustics.
-
Robert Rickel, MS
Researching the integration of electrical sensors into microfluidic devices to sense the microfluidic production of microbubbles for therapeutic applications.
-
Elizabeth Herbst, PhD
Incorporating the use of programmed ultrasound sequences and image processing techniques to detect cancer and cardiovascular disease on a molecular level.
-
Will Mauldin, PhD
Chairman, CEO and Co-Founder of Rivanna Medical
Supporting projects involving ultrasound-based targeted molecular imaging and image processing.
-
Adam Dixon, PhD
Vice President Of Engineering at Rivanna Medical
Supporting projects involving microfluidic production of microbubbles for therapeutic applications and the development of contrast agents for photoacoustic imaging.